/mass-casualty-management-training.tmb-1920v.jpg?sfvrsn=fe57b985_1)
How GCTF works
How GCTF works
GCTF brings together policymakers, researchers, regulators, ethics authorities, funders, patient and community representatives, civil society organisations and other partners to support implementation of World Health Assembly resolution WHA75.8, WHO guidance on best practices for clinical trials and the Global Action Plan for Clinical Trial Ecosystem Strengthening (GAP-CTS).
The Forum supports inclusive dialogue, knowledge sharing and coordinated action to address national, regional and global challenges in clinical research. Its work focuses on improving the quality, efficiency, inclusiveness and impact of clinical trials so that countries and regions can generate robust evidence for public health decision-making.
Global Action Plan for Clinical Trial Ecosystem Strengthening
The Global Action Plan for Clinical Trial Ecosystem Strengthening provides a strategic framework for coordinated action to implement WHO guidance on clinical trials.
The Plan identifies nine priority action areas designed to address barriers in clinical trial ecosystems and support more efficient, inclusive and sustainable clinical research.
GCTF supports implementation of these action areas through dissemination, engagement and advocacy, knowledge sharing, working groups and coordinated member contributions.
Action areas of GAP-CTS
/gap-cts_horizontal.png?sfvrsn=679be6dc_4 "Global action plan for clinical trial ecosystem strengthening action areas")
How members contribute
GCTF works through three main forms of member contribution.
Dissemination
Members help share and amplify WHO norms, standards and guidance to broaden global reach and support uptake across countries and regions.
Examples include:
- translating or adapting WHO products for local or regional use;
- developing communication, training or advocacy materials;
- publishing articles, blogs or commentaries referencing WHO guidance; and
- sharing relevant WHO resources through institutional and regional networks.
Engagement and advocacy
Members support dialogue and advocacy to promote adoption of WHO guidance and strengthen clinical trial ecosystems.
Examples include:
- organising policy dialogues, workshops or briefings;
- producing advocacy materials or campaigns;
- supporting policy or system reforms aligned with WHO recommendations; and
- engaging national, regional or global stakeholders around clinical trial strengthening.
Knowledge sharing
Members contribute expertise, tools, data, case studies and experience to strengthen collective learning across institutions and regions.
Examples include:
- participating in WHO-facilitated working groups;
- sharing good practices, tools or implementation examples;
- contributing to methodological, ethical or operational studies; and
- supporting learning across clinical trial networks, institutions and regions.
Working groups
Working groups provide a practical platform for GCTF members to combine expertise around defined priorities aligned with the Global Action Plan for Clinical Trials Ecosystem Strengthening.
Through working groups, members share knowledge, develop outputs and support coordinated implementation of WHO guidance.